Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  MedGenMed : Medscape general medicine

• Publication date

  2007-08-15

• Fields of study

  Medicine

• Identifiers
  PMID 18092041PMCID PMC2100110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ocular Symptoms of Seasonal Allergic Rhinitis Can Be Treated Effectively With An Inhaled Corticosteroid (Mometasone Furoate Nasal Spray)

  2007cited by this paper
• Allergic diseases of the eye.

  2006cited by this paper
• The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings.

  2006cited by this paper
• Testing a Direct, Highly Sensitivity Method for Quantitation of Fluticasone Propionate in Human Plasma: Contrasting Nasal and Inhaled Exposure

  2006cited by this paper
• Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures

  2006cited by this paper
• Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis.

  2006cited by this paper
• Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine

  2005influential reference
• Prevalence of asthma, allergic rhinoconjunctivitis and allergic sensitization in Mongolia

  2005cited by this paper
• The Economic and Quality of Life Impact of Seasonal Allergic Conjunctivitis in a Spanish Setting

  2005influential reference
• Induction of nasal hyper‐responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves

  2005cited by this paper
• Ocular allergy: diagnosis and treatment.

  2005cited by this paper
• Prevalence of non-vision-impairing conditions in a village in Chakwal district, Punjab, Pakistan

  2004cited by this paper
• The Relation of Conjunctival and Corneal Findings in Severe Ocular Allergies

  2004cited by this paper
• A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis

  2004cited by this paper
• Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis

  2004cited by this paper
• Inflammatory cells in brush cytology samples correlate with the severity of corneal lesions in atopic keratoconjunctivitis

  2004cited by this paper
• Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease

  2004cited by this paper
• No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis

  2004influential reference
• A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.

  2004cited by this paper
• Developments in ocular allergy

  2004cited by this paper
• Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference

  2004cited by this paper
• Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitis

  2003cited by this paper
• Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire.

  2003influential reference
• Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.

  2003cited by this paper
• An evaluation of 1-day disposable contact lens wear in a population of allergy sufferers.

  2003cited by this paper
• Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.

  2003cited by this paper
• Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children.

  2003cited by this paper
• Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.

  2003cited by this paper
• Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study.

  2003cited by this paper
• A combined analysis of two studies assessing the ocular comfort of antiallergy ophthalmic agents.

  2003cited by this paper
• Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Münster, Germany

  2003cited by this paper
• Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey.

  2003cited by this paper
• Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.

  2003cited by this paper
• The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.

  2003cited by this paper
• Tear eotaxin levels in giant papillary conjunctivitis associated with ocular prosthesis

  2003cited by this paper
• Current opinion of immunotherapy for ocular allergy

  2002cited by this paper
• Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity.

  2002cited by this paper
• Update on ocular allergy treatment

  2002cited by this paper
• Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis

  2001cited by this paper
• Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.

  2001cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Allergic conjunctivitis.

  2001cited by this paper
• Allergen immunotherapy: does it work and, if so, how and for how long?

  2000cited by this paper
• Allergen‐specific immunotherapy in birch‐ and grass‐pollen‐allergic rhinitis. II. Side‐effects

  2000cited by this paper
• Giant papillary conjunctivitis in frequent-replacement contact lens wearers: a retrospective study.

  2000cited by this paper
• Allergen‐specific immunotherapy in birch‐ and grass‐pollen‐allergic rhinitis. I. Efficacy estimated by a model reducing the biasof annual differences in pollen counts

  2000cited by this paper
• Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis

  2000cited by this paper
• Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect.

  2000cited by this paper
• Epidemiological study of 134 subjects with allergic conjunctivitis.

  2000cited by this paper
• Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis.

  2000cited by this paper
• Tear and conjunctival changes during the allergen-induced early- and late-phase responses.

  2000cited by this paper
• Giant papillary conjunctivitis in frequent replacement contact lens wearers: a retrospective study.

  1999cited by this paper
• Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood)

  1999cited by this paper
• Cytokine production and mRNA expression by conjunctival T‐cell lines in chronic allergic eye disease

  1999cited by this paper
• Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis.

  1999cited by this paper
• Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long‐term management of vernal keratoconjunctivitis

  1999cited by this paper
• Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.

  1999cited by this paper
• A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis.

  1998cited by this paper
• Allergic eye disease mechanisms

  1998cited by this paper
• Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergy.

  1998cited by this paper
• Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines.

  1998cited by this paper
• Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

  1998cited by this paper
• Epidemiological survey in hay fever patients: symptom prevalence and severity and influence on patient management.

  1998cited by this paper
• Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases.

  1998cited by this paper
• A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.

  1997cited by this paper
• Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration

  1997cited by this paper
• The prevalence and medical and economic impact of allergic rhinitis in the United States.

  1997cited by this paper
• Prevalence of allergic rhinitis in the United States

  1997cited by this paper
• Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology.

  1997cited by this paper
• Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis.

  1997cited by this paper
• Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children.

  1997cited by this paper
• Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)

  1997cited by this paper
• Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2

  1996cited by this paper
• Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure.

  1996cited by this paper
• Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.

  1996cited by this paper
• Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS).

  1996cited by this paper
• Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up study

  1995cited by this paper
• The efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitis

  1995cited by this paper
• Effect of Age on Tear Osmolality

  1995cited by this paper
• Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study.

  1995cited by this paper
• A double‐blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen

  1994cited by this paper
• A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

  1994cited by this paper
• Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.

  1994cited by this paper
• Effect of nasal anaesthesia on lacrimal function after nasal allergen challenge

  1994cited by this paper
• Conjunctivitis medicamentosa.

  1994cited by this paper
• Local specific immunotherapy in allergic conjunctivitis

  1994cited by this paper
• A double‐blind, placebo‐controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

  1994cited by this paper
• A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

  1994cited by this paper
• Rapid onset of action of levocabastine eye‐drops in histamine‐induced conjunctivitis

  1993cited by this paper
• Heterogeneity of atopy. I. Clinical and immunologic characteristics of patients allergic to cypress pollen

  1993cited by this paper
• Practical problems with eye-drops among elderly ophthalmology outpatients.

  1992cited by this paper
• Immunotherapy in allergic conjunctivitis.

  1992cited by this paper
• Efficacy and safety of cetirizine therapy in perennial allergic rhinitis.

  1992cited by this paper
• Double‐blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis

  1991cited by this paper
• The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.

  1991cited by this paper
• Protective effect of loratadine on specific conjunctival provocation test.

  1991cited by this paper
• Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis.

  1990cited by this paper
• Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis.

  1990cited by this paper
• Effect of cetirizine in a conjunctival provocation test with allergens

  1990cited by this paper
• Nasal reactions elicited by unilateral allergen challenge.

  1989cited by this paper

• Neue und zukünftige Therapieansätze in der Behandlung der allergischen Konjunktivitis

  2024cites this paper
• Ocular morbidity in children with allergic conjunctivitis: A rural-urban survey

  2023cites this paper
• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• Dermatoparasitoses in Referral Patients to the Laboratory

  2022cites this paper
• Safety and efficacy of sodium cromoglycate-fluorometholone fixed combination eye drops in allergic conjunctivitis

  2022cites this paper
• Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis

  2021cites this paper
• ICON

  2020cites this paper
• Efficacy of Topical Cyclosporine in the Treatment of Atopicand Vernal Keratoconjunctivitis

  2020cites this paper
• Trends in licence approvals for ophthalmic medicines in the United Kingdom

  2020cites this paper
• Immune Mechanisms, Pathology, and Management of Allergic Ocular Diseases

  2020cites this paper
• The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option

  2019cites this paper
• Monoclonal B-cell lymphocytosis and prostate cancer: incidence and effects of radiotherapy

  2019cites this paper
• ICON: Diagnosis and Management of Allergic Conjunctivitis.

  2019cites this paper
• Sublingual immunotherapy for pediatric allergic conjunctivitis: a meta‐analysis of randomized controlled trials

  2018cites this paper
• Demodex blepharitis: clinical perspectives

  2018cites this paper
• Does the temperature of an artificial tear affect its comfort?

  2018cites this paper
• Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis

  2018influential citation
• Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials

  2018cites this paper
• Characterization of impurities in sodium cromoglycate drug substance and eye drops using LC‐ESI‐ion trap MS and LC‐ESI‐QTOF MS

  2017cites this paper
• Allergic eye disease

  2017cites this paper
• Correlation of tear film-specific immunoglobulin E assay with the skin prick test in allergic conjunctivitis

  2017cites this paper
• COMPOSITIONS COMPRISING AZELASTINE AND METHODS OF USE THEREOF

  2017cites this paper
• SIDE EFFECTS OF LOCAL CORTICOSTEROID THERAPY ( MAXIDROL AND CHIBROCADRON EYE DROPS ) AMONG PATIENTS WITH ALLERGIC CONJUNCTIVITIS . A STUDY DONE IN KUTH , KIGALI RWANDA

  2017cites this paper
• Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study

  2016cites this paper
• Optical densitometric measurements of the cornea and lens in children with allergic rhinoconjunctivitis

  2016cites this paper
• Effectiveness of Supratarsal Triamcinolone Injection in Patients with Vernal Keratoconjunctivitis

  2015cites this paper
• Component-resolved diagnostics in vernal conjunctivitis.

  2015cites this paper
• Consensus document on allergic conjunctivitis (DECA).

  2015cites this paper
• Experience Of Ocular Symptoms Among Allergic Rhinitis Patients Depending On The Type Of Aeroallergens

  2015cites this paper
• Allergie oculaire de l’enfant : impact sur la qualité de vie et retentissement psychologique

  2013cites this paper
• Pharmacotherapeutic strategies for allergic rhinitis: matching treatment to symptoms, disease progression, and associated conditions.

  2013cites this paper
• Vernal Keratoconjunctivitis : A Teaching Case Report

  2013cites this paper
• Allergic conjunctivitis: an update on diagnosis and management

  2013cites this paper
• The anatomical and functional relationship between allergic conjunctivitis and allergic rhinitis

  2013cites this paper
• Allergic conjunctivitis: a comprehensive review of the literature

  2013cites this paper
• The Anti-Inflammatory Effects of Therapies for Ocular Allergy

  2013cites this paper
• A Scientific Review and Expert Case Debate

  2013cites this paper
• Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis

  2013cites this paper
• Ocular Allergy: A Scientific Review and Expert Case Debate

  2013cites this paper
• Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

  2012cites this paper
• Management of seasonal allergic conjunctivitis: guide to therapy

  2012influential citation
• Identification of genes and proteins specifically regulated by costimulation of mast cell Fcε Receptor I and chemokine receptor 1.

  2012cites this paper
• Clinical epidemiology of IgE-mediated cutaneous and oculo-conjunctival allergic diseases

  2012cites this paper
• Optimizing Refractive Outcomes in the Presence of Ocular Allergy—Toward a Comprehensive Approach to Ocular Surface Health

  2012cites this paper
• Should Intranasal Corticosteroids Be Used for the Treatment of Ocular Symptoms of Allergic Rhinoconjunctivitis? A Review of Their Efficacy and Safety Profile

  2012cites this paper
• Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis

  2012cites this paper
• Sublingual immunotherapy for treating allergic conjunctivitis.

  2011cites this paper
• evaluation of olopatadine 0.2% in the complete prevention of ocular itching in the conjunctival allergen challenge model

  2011cites this paper
• Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta‐analysis

  2011cites this paper
• Efficacité des corticoïdes par voie nasale sur les symptômes oculaires de la rhinite allergique

  2010cites this paper
• Vernal itis: A Teaching Case Report

  2010cites this paper
• Conjunctival effects of a selective nasal pollen provocation

  2010influential citation
• Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis

  2010cites this paper
• Immunochromatographic Assay for Measurement of Total IgE in Tears, Nasal Mucus, and Saliva of Patients with Allergic Rhinoconjunctivitis

  2010cites this paper
• Evaluation of desloratadine on conjunctival allergen challenge‐induced ocular symptoms

  2009cites this paper
• Dermatoceratoconjuntivite atópica em pacientes do Ambulatório de Dermatologia Infanto-Juvenil em centro de referência

  2009cites this paper
• Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen*

  2009cites this paper
• [Atopic keratoconjunctivitis in patients of the pediatric dermatology ambulatory in a reference center].

  2009cites this paper
• Burden of allergic rhinitis: results from the Pediatric Allergies in America survey.

  2009cites this paper
• Title: Study on the prevalence of childhood eye morbidities in a rural region in Karnataka state, Southern India

  2009cites this paper
• The management of allergic eye diseases in primary eye care.

  2009influential citation
• Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergológica-2005.

  2009cites this paper
• Emerging drugs for conjunctivitis

  2009cites this paper
• Intranasal corticosteroids: Do they improve ocular allergy?

  2009cites this paper
• A simple and rapid diagnostic algorithm for the detection of ocular allergic diseases

  2009cites this paper
• Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data.

  2008cites this paper
• Pediatric allergic conjunctivitis and allergic rhinitis

  2008cites this paper
• Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data

  2008cites this paper
• Allergic Conjunctivitis : New Strategies for Treatment Clinicians can better manage allergic conjunctivitis by improving their understanding of their patients ’ mindset and circumstances as well as their ocular health

  year unknowncites this paper